XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Activity related to restricted stock units The activity related to restricted stock units for the year ended December 31, 2022 is as follows:
NonvestedVested
Total
Average Grant
Date Fair
Value Per Share
Outstanding, December 31, 2021332,597 82,264 414,861 $53.32 
   Granted291,365 — 291,365 $53.55 
   Vested(111,333)111,333 — 
   Converted(122,337)(122,337)$53.62 
   Cancelled(51,908)— (51,908)$55.04 
   Dividend equivalents1,674 2,049 3,723 $56.33 
Outstanding, December 31, 2022462,395 73,309 535,704 $53.23 
Activity related to performance contingent restricted stock units The activity related to performance contingent restricted stock units for the year ended December 31, 2022 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value per Share
Outstanding, December 31, 2021480,653 97,653 578,306 $53.67
   Granted201,835 — 201,835 $51.94
   Performance adjustments304,554 — 304,554 $51.96
   Vested(280,881)280,881 — 
   Converted— (77,167)(77,167)$52.62
   Cancelled(106,779)— (106,779)$53.59
   Dividend equivalents— 1,033 1,033 $59.32
Outstanding, December 31, 2022599,382 302,400 901,782 $52.81
Company's SARs
The activity related to the Company’s SARs for the year ended December 31, 2022 is as follows: 
NonvestedVestedTotal
Weighted-
average
Exercise
Price
Outstanding, December 31, 2021124,164 755,507 879,671 $55.03 
   Vested(124,164)124,164 — 
   Granted— — — $— 
   Exercised— (105,681)(105,681)$55.20 
   Forfeited/Expired— (9,184)(9,184)$57.45 
Outstanding, December 31, 2022— 764,806 764,806 $54.98 
Exercisable, December 31, 2022— 764,806 764,806 $54.98 
Schedule of other share-based compensation, activity The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2021380,757 
   Deferred37,617 
   Converted(144,244)
   Dividend equivalents12,885 
Outstanding, December 31, 2022287,015